Author:
Hofman Michael S.,Hicks Rodney J.
Publisher
Springer Berlin Heidelberg
Reference100 articles.
1. Donohoe KJ, Brown ML, Collier BD et al (2003) Procedure guidelines for bone scintigraphy: 3.0.Society of Nuclear Medicine.
http://interactive.snm.org/docs/pg_ch34_0403.pdf
2. (2010) NCCN clinical practice guidelines in oncology: breast cancer v.2.2010
3. Abe K, Sasaki M, Kuwabara Y et al (2005) Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer. Ann Nucl Med 19(7):573–579
4. Aboagye EO, Bhujwalla ZM (1999) Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 59(1):80–84
5. Beauregard J-M, Croteau E, Ahmed N et al (2009) Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT. J Nucl Med 50:100–107